XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating expenses:    
Research and development $ 18,736 $ 22,963
General and administrative 5,145 4,288
Total operating expenses 23,881 27,251
Loss from operations (23,881) (27,251)
Other income (expense):    
Interest income 1,187 800
Change in fair value of the tranche rights (4,796) 0
Other income (expense), net (2,094) 1,179
Total other income (expense) (5,703) 1,979
Net loss $ (29,584) $ (25,272)
Net loss per share, basic (in USD per share) $ (0.30) $ (0.58)
Net loss per share, diluted (in USD per share) $ (0.30) $ (0.58)
Weighted-average common shares outstanding, basic (in shares) 97,299,955 43,664,783
Weighted-average common shares outstanding, diluted (in shares) 97,299,955 43,664,783